An open-label, sequential, dose-finding study of peginesatide for the maintenance treatment of anemia in chronic hemodialysis patients

BACKGROUND: Peginesatide is a peptide-based erythropoiesis-stimulating agent that was designed and engineered to stimulate specifically the erythropoietin receptor dimer that governs erythropoiesis. The primary objective of this phase 2 dose-finding study was to determine the once-monthly peginesati...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Besarab, Anatole, Zeig, Steven N, Martin, Edouard R, Pergola, Pablo E, Whittier, Frederick C, Zabaneh, Raja I, Schiller, Brigitte, Mayo, Martha, Francisco, Carol A, Polu, Krishna R, Duliege, Anne-Marie
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2012
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3511162/
https://ncbi.nlm.nih.gov/pubmed/22935486
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2369-13-95
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky